Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

Daiichi Sankyo steps out after Sun-Ranbaxy merger

22 April 2015 Business

Ranbaxy’s Japanese owner has sold off its stake in the merged company, but will retain its business partnership

Generics giant Mylan offers $30 billion for Perrigo

13 April 2015 Business

Mylan makes ambitious takeover offer just weeks after Abbott aquisition closes

BMS invests in gene therapy

9 April 2015 Business

Bristol-Myers Squibb makes $100 million deal with biotech uniQure

Leak causes explosion at para-xylene plant in China

8 April 2015 Business

Twelve injured by explosion and fire caused by a leaking xylene tank at chemical plant

Horizon to acquire orphan drugs in $1.1bn Hyperion takeover

2 April 2015 Business

Horizon will buy Hyperion and add new drugs to its rare disease portfolio

Novartis accused of ‘derailing’ trials for cheap eye disease drug

2 April 2015 Business

BMJ says pharma giant is trying to block access to a drug that would save the NHS millions

Teva buys Auspex Pharmaceuticals for $3.2bn

1 April 2015 Business

Generics giant will add late stage Huntingdon’s drug to CNS portfolio

­Dow sells off chlorine assets in $5bn deal

1 April 2015 Business

US chemical giant disposes of unwanted operations in tax-free deal

Environmental research goes private

1 April 2015 Business

Exclusive interview with Fera chief Hilary Aldridge as the UK's Food and Environment Research Agency becomes majority-owned by Capita

Sun Pharma snares Ranbaxy in $4bn deal

1 April 2015 Business

Acquisition makes Sun biggest drug firm in India and fifth largest generics producer in the world

Valeant heads off Endo bid for Salix

25 March 2015 Business

Bid raised to $15.8 billion in cash after rival offer from Irish firm

23andMe jumps into drug R&D

23 March 2015 Business

Gene profiling firm aims to capitalise on its databank of genetic information to discover new drugs

Drug firms warned to be honest with investors

16 March 2015 Business

Official warns of ‘significant consequences’ if companies aren’t forthcoming about their FDA interactions

BASF introduces bio-based polyTHF

13 March 2015 Business

Process uses 1,4-butanediol from microbial digestion of sugar feedstocks to make component of polyester and polyurethane materials

Amgen to axe 300 Onyx employees

13 March 2015 Business

Amgen will close its Onyx facility in South San Francisco in December

Mergers and moves trigger pharma layoffs

11 March 2015 Business

Shire expects to sack 500 or more employees, while Merck and GSK also wield the axe

US approves biosimilar filgrastim

10 March 2015 Business

Sandoz’s version of Amgen’s Neupogen is ‘biosimilar’ but not ‘interchangeable’

AbbVie to buy Pharmacyclics for pipeline boost

10 March 2015 Business

$21bn deal gives AbbVie a share in sales of blockbuster cancer drug as its own biggest sellers face patent expiry

Mallinckrodt to buy Ikaria to expand in US hospitals

9 March 2015 Business

$2.3bn deal brings nitric oxide ventilator system for newborns with respiratory failure

J&J to sell cardiac devices to wholesaler Cardinal

3 March 2015 Business

Commodity technology no longer fits with company’s focus on growth and innovation

AstraZeneca to spin off anti-infectives research

2 March 2015 Business

Early-stage research will transfer to a new company, while AZ and MedImmune retain late-stage programmes

Asahi Kasei to buy Polypore for battery materials

26 February 2015 Business

$2.2bn deal adds to Japanese consolidation in energy storage

US opens up home DNA screening

25 February 2015 Business

FDA approves single disease genetic test and clears pathway for similar devices

B-MS bolsters immuno-oncology with pair of deals

24 February 2015 Business

Firm will acquire Flexus Biosciences and collaborate with Rigel

Catalytic carbon dioxide convertors

24 February 2015 Business

Company profile: Econic Technologies makes catalysts that build carbon dioxide into performance polymers